Nutex Health (NASDAQ:NUTX) Stock Price Up 5.8% – Should You Buy?

Nutex Health Inc. (NASDAQ:NUTX)’s share price shot up 5.8% during mid-day trading on Thursday . The stock traded as high as $146.94 and last traded at $144.78. 62,315 shares were traded during mid-day trading, an increase of 14% from the average session volume of 54,837 shares. The stock had previously closed at $136.89.

Analysts Set New Price Targets

Separately, Maxim Group lifted their target price on Nutex Health from $75.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, April 8th.

Nutex Health Stock Performance

The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36. The firm has a market capitalization of $823.67 million, a PE ratio of -15.87 and a beta of 0.27. The firm’s fifty day moving average price is $69.23 and its 200 day moving average price is $45.04.

Nutex Health (NASDAQ:NUTX) last issued its earnings results on Monday, March 31st. The company reported $11.12 EPS for the quarter, beating analysts’ consensus estimates of ($0.09) by $11.21. The firm had revenue of $81.30 million for the quarter, compared to the consensus estimate of $81.13 million. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%.

Insider Buying and Selling at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates acquired 1,000 shares of Nutex Health stock in a transaction that occurred on Tuesday, April 8th. The stock was acquired at an average price of $81.81 per share, with a total value of $81,810.00. Following the purchase, the chief financial officer now owns 4,888 shares in the company, valued at approximately $399,887.28. This trade represents a 25.72 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 38.52% of the company’s stock.

Institutional Trading of Nutex Health

Institutional investors and hedge funds have recently made changes to their positions in the stock. Bank of America Corp DE lifted its holdings in Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after purchasing an additional 2,043 shares during the last quarter. Beaird Harris Wealth Management LLC acquired a new stake in shares of Nutex Health in the third quarter worth $69,000. Northern Trust Corp bought a new stake in shares of Nutex Health during the 4th quarter worth $200,000. Baader Bank Aktiengesellschaft acquired a new position in Nutex Health in the 4th quarter valued at $206,000. Finally, Millennium Management LLC bought a new position in Nutex Health in the 4th quarter worth $213,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.